Promising immunotherapy treatment targets multiple pathogenic hallmarks of Alzheimer's disease

Medical Xpress quoted Jonathan Lovell  in an article about developing a novel immunotherapy approach to Alzheimer’s disease treatment that targets multiple epitopes.